Regulatory Product Development.
Building regulatory strategy into product development from discovery through market access.
Before You Build, Know the Pathway
The MediLife Digital Health 10-Step Regulatory Pathway — a framework for digital health and SaMD market entry across the UK, EU and US.
Read the article →Why Regulatory Strategy Should Start Before You Build Your Digital Health Product
Regulatory strategy isn't a submission activity. It's a product development activity.
Read the article →EU MDR vs FDA: Why Your Device Classification Doesn't Simply Translate
The EU and FDA classify medical device software using different logic — the same product can land in a different place in each system.
Read the article →510(k), De Novo or PMA? Understanding the FDA Pathway Before Development Starts
Three pathways, three very different evidence, timeline and testing burdens.
Read the article →Why Your FDA Predicate Strategy Can Influence What You Build
Predicate selection can shape your claims, your testing and your architecture — if you look early enough.
Read the article →Your Technical File Shouldn't Be Something You Write at the End
A Technical File is compiled evidence, not a report — and evidence has to be generated as it happens.
Read the article →When Should Regulatory Actually Engage With Product and Engineering?
Not a point in time — a question of which decisions carry regulatory weight, and when they get made.
Read the article →More articles in this series are in progress.